1. Home
  2. Analysis
  3. Doxepin-hydrochloride
  4. Tramadol

Doxepin hydrochloride and Tramadol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Doxepin hydrochloride and Tramadol. Common interactions include nasal discomfort among females and cholecystitis infective among males.

The phase IV clinical study analyzes what interactions people who take Doxepin hydrochloride and Tramadol have. It is created by eHealthMe based on reports of 60 people who take Doxepin hydrochloride and Tramadol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 31, 2023

60 people who take Doxepin hydrochloride and Tramadol together, and have interactions are studied.

What is Doxepin hydrochloride?

Doxepin hydrochloride has active ingredients of doxepin hydrochloride. It is often used in insomnia. eHealthMe is studying from 1,963 Doxepin hydrochloride users for its effectiveness, alternative drugs and more.

What is Tramadol?

Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 200,135 Tramadol users for its effectiveness, alternative drugs and more.

Number of Doxepin hydrochloride and Tramadol reports submitted per year:

Doxepin hydrochloride and Tramadol drug interactions.

Common Doxepin Hydrochloride and Tramadol drug interactions by gender *:

female:

  1. Nasal discomfort
  2. Neck pain
  3. Nephrolithiasis
  4. Nervousness
  5. Neuropathy peripheral
  6. Overdose
  7. Pneumonia
  8. Radial nerve palsy
  9. Rib fracture
  10. Sepsis

male:

  1. Cholecystitis infective
  2. Cholelithiasis
  3. Decreased immune responsiveness
  4. Drug ineffective
  5. Erythema of eyelid
  6. Eye infection
  7. Eye pain
  8. Eye pruritus
  9. Impaired driving ability
  10. Ocular hyperaemia

Common Doxepin Hydrochloride and Tramadol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Drug toxicity
  2. Cardio-respiratory arrest
  3. Completed suicide
  4. Drug abuse

40-49:

  1. Eye swelling
  2. Conjunctivitis
  3. Decreased immune responsiveness
  4. Erythema of eyelid
  5. Eye infection
  6. Eye pain
  7. Eye pruritus
  8. Impaired driving ability
  9. Ocular hyperaemia
  10. Pneumonia

50-59:

  1. Sepsis
  2. Suicide attempt
  3. Urinary tract infection
  4. Bundle branch block left
  5. Cardiac failure
  6. Cardiac failure congestive
  7. Cardiomegaly
  8. Completed suicide
  9. Dysarthria
  10. Hypertensive heart disease

60+:

  1. Cholecystitis infective
  2. Cholelithiasis
  3. Weight decreased
  4. Drug hypersensitivity
  5. Aggression
  6. Diarrhoea
  7. Hypoacusis
  8. Pain in extremity
  9. Pulmonary oedema
  10. Staphylococcal infection

Common conditions people have *:

  1. Diabetes: 9 people, 15.00%
  2. Essential Hypertension (primary hypertension): 7 people, 11.67%
  3. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 10.00%
  4. Depression: 6 people, 10.00%
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 6 people, 10.00%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 10.00%
  7. Hypoaesthesia (reduced sense of touch or sensation): 6 people, 10.00%
  8. Gout (uric acid crystals building up in the body): 6 people, 10.00%
  9. Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 6 people, 10.00%
  10. Prostatomegaly (enlargement of the prostate): 6 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Doxepin hydrochloride and Tramadol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Doxepin hydrochloride and Tramadol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Doxepin hydrochloride side effects:

Browse all side effects of Doxepin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tramadol side effects:

Browse all side effects of Tramadol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Doxepin hydrochloride interactions:

Browse all interactions between Doxepin hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tramadol interactions:

Browse all interactions between Tramadol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on doxepin hydrochloride and tramadol hydrochloride (the active ingredients of Doxepin hydrochloride and Tramadol, respectively), and Doxepin hydrochloride and Tramadol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Doxepin hydrochloride and Tramadol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.